| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2155259 | Pathology - Research and Practice | 2015 | 5 Pages |
Abstract
High CD1a-positive dendritic cell density is associated with improved disease-free survival in PTC. The specificity of anti-CD1a immunostain for activated dendritic cells may explain the better outcome prediction in this study than in studies using S100 protein.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ohad Hilly, Lea Rath-Wolfson, Rumelia Koren, Aviram Mizrachi, Yaniv Hamzany, Gideon Bachar, Thomas Shpitzer,